Stage IB Pancreatic Cancer Completed Phase 2 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0034490 (Stage IB Pancreatic Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00305877Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By SurgeryTreatment